Dose finding study for the use of subcutaneous recombinant interleukin-2 to augment natural killer cell numbers in an outpatient setting for stage 4 neuroblastoma after megatherapy and autologous stem-cell reinfusion (Q40340892)
Jump to navigation
Jump to search
scientific article published on 13 December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose finding study for the use of subcutaneous recombinant interleukin-2 to augment natural killer cell numbers in an outpatient setting for stage 4 neuroblastoma after megatherapy and autologous stem-cell reinfusion |
scientific article published on 13 December 2010 |
Statements
1 reference
Dose finding study for the use of subcutaneous recombinant interleukin-2 to augment natural killer cell numbers in an outpatient setting for stage 4 neuroblastoma after megatherapy and autologous stem-cell reinfusion (English)
1 reference
Ulrike Pötschger
1 reference
Ruth Ladenstein
1 reference
Dimitris Siabalis
1 reference
Alberto Garaventa
1 reference
Christophe Bergeron
1 reference
Ian J Lewis
1 reference
Jerry Stein
1 reference
Janice Kohler
1 reference
Peter J Shaw
1 reference
Wolfgang Holter
1 reference
Vito Pistoia
1 reference
Jean Michon
1 reference
13 December 2010
1 reference
1 reference
29
1 reference
4
1 reference
441-448
1 reference
Identifiers
1 reference
1 reference